Featured Research

from universities, journals, and other organizations

Can the zebrafish help us to search for new pain drugs?

Date:
September 3, 2013
Source:
Sbarro Health Research Organization (SHRO)
Summary:
Neuropathic pain is caused by injury of the central or peripheral nervous system. Neuropathic pain is difficult to treat because rarely responds to opiates. Studying neuropathic pain in humans has major ethical and experimental limitations. The use of alternate mammalian animal models has been the solution for many years. For both human and animal studies scientists had to rely frequently on behavioral tests that may not directly reflect the experience the animal is going through. Thus, this may be one of the reasons because our ability to treat pain symptoms still relies on a small number of drugs. This suggests that the use of other model systems may help to discovery new compounds with potential analgesic activity.

Neuropathic pain is caused by injury of the central or peripheral nervous system. Neuropathic pain is difficult to treat because rarely responds to opiates. Studying neuropathic pain in humans has major ethical and experimental limitations. The use of alternate mammalian animal models has been the solution for many years. For both human and animal studies scientists had to rely frequently on behavioral tests that may not directly reflect the experience the animal is going through. Thus, this may be one of the reasons because our ability to treat pain symptoms still relies on a small number of drugs. This suggests that the use of other model systems may help to discovery new compounds with potential analgesic activity.

A new published study in Journal of Cellular Physiology by a team led by Dr. Antonio Giordano and Dr. Gianfranco Bellipanni of Sbarro Institute for Cancer Research and Molecular Medicine and Temple University (Philadelphia, USA) adds a new prospective on the research on pain perception. They used larvae of the small vertebrate zebrafish to show that at the molecular level they respond to stimuli that induce inflammation and axons degenerations similarly to mammals.

"We found the highest temperature zebrafish larvae could survive and exposed them for only 5 seconds, the results where similar to human severe skin burns. " Dr. Giordano said. " Then we went to see if the panel of genes, activated by pain in humans, was activated also in the fish. Interestingly, they were activated at the right place and time."

We asked Dr. Gianfranco Bellipanni to explain how this research could have implications for humans: "to understand better the mechanism of neuropathic pain and to discovery new drugs first we need an animal model that is easy and economic to keep, that shows a high degree of similarity in pain perception and response with mammals and is especially able to offer many technical tools for conducting studies.

Zebrafish matches all these characteristics" he said. " Now we are creating transgenic zebrafish that became fluorescent in response to painful stimulations. These transgenic fish can be used for in vivo studies. At first we will use these transgenic fish to characterize better the cellular and molecular mechanisms of pain, but our final goal, if we will find the appropriate funding, is to use them for screening for chemicals with potential analgesic activity."

Other authors of the study include Dr. Valentina Malafoglia and William Raffaeli both at ISAL-Foundation, Institute for Research on Pain, Dr. Marco Colasanti at University of Roma3 and Dr. Darius Balciunas at Temple University.


Story Source:

The above story is based on materials provided by Sbarro Health Research Organization (SHRO). Note: Materials may be edited for content and length.


Journal Reference:

  1. Valentina Malafoglia, Marco Colasanti, William Raffaeli, Darius Balciunas, Antonio Giordano, Gianfranco Bellipanni. Extreme thermal noxious stimuli induce pain responses in zebrafish larvae. Journal of Cellular Physiology, 2013; DOI: 10.1002/jcp.24447

Cite This Page:

Sbarro Health Research Organization (SHRO). "Can the zebrafish help us to search for new pain drugs?." ScienceDaily. ScienceDaily, 3 September 2013. <www.sciencedaily.com/releases/2013/09/130903090908.htm>.
Sbarro Health Research Organization (SHRO). (2013, September 3). Can the zebrafish help us to search for new pain drugs?. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130903090908.htm
Sbarro Health Research Organization (SHRO). "Can the zebrafish help us to search for new pain drugs?." ScienceDaily. www.sciencedaily.com/releases/2013/09/130903090908.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins